Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients With Metastatic Castration-Resistant Prostate Cancer

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
doi 10.31556/2219-0678.2018.33.3.062-074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Fund Gelios

Related search

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie
Oncology
2016English

Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients

Clinical Cancer Research
Cancer ResearchOncology
2017English

Cabazitaxel in the Management of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel-Based Chemotherapy

European Oncology and Haematology
OncologyHematology
2012English

Economic Evaluations of Cabazitaxel for Treatment of Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer: Evidence From a Systematic Review

Journal of Pharmaceutical Research International
2019English

Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer

Japanese Journal of Urology
Urology
2016English

Clinical Concepts for Cabazitaxel in the Management of Metastatic Castration‐resistant Prostate Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients

Cancer Treatment and Research Communications
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy